Dissolution rate enhancement of the anti-inflammatory drug diflunisal by coprecipitation with a biocompatible polymer using carbon dioxide as a supercritical fluid antisolvent

[1]  A. Narang,et al.  Impact of Excipient Interactions on Drug Bioavailability from Solid Dosage Forms , 2012, Pharmaceutical Research.

[2]  J. Renuncio,et al.  Role of excess molar enthalpies in supercritical antisolvent micronizations using dimethylsulfoxide as the polar solvent , 2011 .

[3]  M. R. Silva,et al.  Pyrazinamide-Diflunisal: A New Dual-Drug Co-Crystal , 2011 .

[4]  J. Veciana,et al.  High Loading of Gentamicin in Bioadhesive PVM/MA Nanostructured Microparticles Using Compressed Carbon-Dioxide , 2011, Pharmaceutical Research.

[5]  J. Renuncio,et al.  Excess Molar Enthalpies of CO2 + Acetone at Pressures from (9.00 to 18.00) MPa and Temperatures from (313.15 to 333.15) K , 2010 .

[6]  A. Leipertz,et al.  Interactions of phase equilibria, jet fluid dynamics and mass transfer during supercritical antisolvent micronization , 2010 .

[7]  M. C. Martínez‐Ohárriz,et al.  Dissolution kinetics for coprecipitates of diflunisal with PVP K30 , 1998, European Journal of Drug Metabolism and Pharmacokinetics.

[8]  Géza Horváth,et al.  Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologies. , 2009, International journal of pharmaceutics.

[9]  M. J. Cocero,et al.  Encapsulation and co-precipitation processes with supercritical fluids: Fundamentals and applications , 2009 .

[10]  M. H. Gil,et al.  Solubility of Diflunisal in Supercritical Carbon Dioxide , 2008 .

[11]  P. Fagan,et al.  Chitosan microspheres for encapsulation of alpha-lipoic acid. , 2008, International journal of pharmaceutics.

[12]  M. J. Cocero,et al.  Micronization processes with supercritical fluids: fundamentals and mechanisms. , 2008, Advanced drug delivery reviews.

[13]  K. Byrappa,et al.  Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications. , 2008, Advanced drug delivery reviews.

[14]  E. Reverchon,et al.  Expanded micro-particles by supercritical antisolvent precipitation: Interpretation of results , 2008 .

[15]  R. Davé,et al.  Effect of solvent strength and operating pressure on the formation of submicrometer polymer particles in supercritical microjets , 2007 .

[16]  Enza Torino,et al.  Nanoparticles production by supercritical antisolvent precipitation: A general interpretation , 2007 .

[17]  E. Reverchon,et al.  Drug–polymer microparticles produced by supercritical assisted atomization , 2007, Biotechnology and bioengineering.

[18]  M. Mosharraf,et al.  Formulation, lyophilization and solid-state properties of a pegylated protein. , 2007, International journal of pharmaceutics.

[19]  A. Duarte,et al.  Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques. , 2007, International journal of pharmaceutics.

[20]  Lawrence X. Yu,et al.  A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. , 2006, Molecular pharmaceutics.

[21]  Amit Kumar,et al.  Analytical techniques used to characterize drug-polyvinylpyrrolidone systems in solid and liquid states – An overview , 2006 .

[22]  H. Brittain,et al.  Solid-State Fluorescence Studies of Some Polymorphs of Diflunisal* , 2005, Pharmaceutical Research.

[23]  E. Reverchon,et al.  Role of Phase Behavior and Atomization in the Supercritical Antisolvent Precipitation , 2003 .

[24]  P. Subra,et al.  High-Pressure Vapor−Liquid Equilibrium for the Binary Systems Carbon Dioxide + Dimethyl Sulfoxide and Carbon Dioxide + Dichloromethane , 2002 .

[25]  M. C. Martínez‐Ohárriz,et al.  Solid Dispersions of Diflunisal–PVP: Polymorphic and Amorphous States of the Drug , 2002, Drug development and industrial pharmacy.

[26]  E. Reverchon.  SUPERCRITICAL ANTISOLVENT PRECIPITATION OF MICRO- AND NANO-PARTICLES , 1999 .

[27]  E. Yonemochi,et al.  Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  C. B. Roberts,et al.  Critical Properties of Dilute Carbon Dioxide + Entrainer and Ethane + Entrainer Mixtures , 1998 .

[29]  P. Brooks,et al.  Use and benefits of nonsteroidal anti-inflammatory drugs. , 1998, The American journal of medicine.

[30]  E. Reverchon,et al.  Supercritical Antisolvent Precipitation of Nanoparticles of Superconductor Precursors , 1998 .

[31]  M. C. Martínez‐Ohárriz,et al.  Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form. , 1994, Journal of pharmaceutical sciences.

[32]  T. Nagai,et al.  Studies on powdered preparation. XVII. Dissolution rate of sulfonamides by rotating disk method. , 1966, Chemical and pharmaceutical bulletin.

[33]  J. Eldridge,et al.  The System Carbon Dioxide-Methylene Chloride. Solubility, Vapor Pressure, Liquid Density, and Activity Coefficients. , 1963 .